Advanced search
Publication Cover
Blood Pressure Volume 11, 2002 - Issue 2
Submit an article Journal homepage
492
Views
44
CrossRef citations to date
0
Altmetric
Research Article

Antihypertensive Efficacy and Tolerability of Lercanidipine in Daily Clinical Practice. The ELYPSE Study

Vivencio Barrios From Hospital Ramony Cajal, Madrid; Recordati-Spain, Madrid; Pharmazan-Spain, Barcelona; Hospital Clonico San Carlos, Madrid; School of Medicine, Universidad Complutense, Madrid; Hospital 12 de Octubre, Madrid, Spain
,
Angel Navarro From Hospital Ramony Cajal, Madrid; Recordati-Spain, Madrid; Pharmazan-Spain, Barcelona; Hospital Clonico San Carlos, Madrid; School of Medicine, Universidad Complutense, Madrid; Hospital 12 de Octubre, Madrid, Spain
,
Antonio Esteras From Hospital Ramony Cajal, Madrid; Recordati-Spain, Madrid; Pharmazan-Spain, Barcelona; Hospital Clonico San Carlos, Madrid; School of Medicine, Universidad Complutense, Madrid; Hospital 12 de Octubre, Madrid, Spain
,
Manuel Luque From Hospital Ramony Cajal, Madrid; Recordati-Spain, Madrid; Pharmazan-Spain, Barcelona; Hospital Clonico San Carlos, Madrid; School of Medicine, Universidad Complutense, Madrid; Hospital 12 de Octubre, Madrid, Spain
,
Joaquima Romero From Hospital Ramony Cajal, Madrid; Recordati-Spain, Madrid; Pharmazan-Spain, Barcelona; Hospital Clonico San Carlos, Madrid; School of Medicine, Universidad Complutense, Madrid; Hospital 12 de Octubre, Madrid, Spain
,
Juan Tamargo From Hospital Ramony Cajal, Madrid; Recordati-Spain, Madrid; Pharmazan-Spain, Barcelona; Hospital Clonico San Carlos, Madrid; School of Medicine, Universidad Complutense, Madrid; Hospital 12 de Octubre, Madrid, Spain
,
Luis Prieto From Hospital Ramony Cajal, Madrid; Recordati-Spain, Madrid; Pharmazan-Spain, Barcelona; Hospital Clonico San Carlos, Madrid; School of Medicine, Universidad Complutense, Madrid; Hospital 12 de Octubre, Madrid, Spain
,
Jose Luis Carrasco From Hospital Ramony Cajal, Madrid; Recordati-Spain, Madrid; Pharmazan-Spain, Barcelona; Hospital Clonico San Carlos, Madrid; School of Medicine, Universidad Complutense, Madrid; Hospital 12 de Octubre, Madrid, Spain
,
Inmaculada Herranz From Hospital Ramony Cajal, Madrid; Recordati-Spain, Madrid; Pharmazan-Spain, Barcelona; Hospital Clonico San Carlos, Madrid; School of Medicine, Universidad Complutense, Madrid; Hospital 12 de Octubre, Madrid, Spain
,
Josefa Navarro-Cid From Hospital Ramony Cajal, Madrid; Recordati-Spain, Madrid; Pharmazan-Spain, Barcelona; Hospital Clonico San Carlos, Madrid; School of Medicine, Universidad Complutense, Madrid; Hospital 12 de Octubre, Madrid, Spain
&
Luis M. Ruilope From Hospital Ramony Cajal, Madrid; Recordati-Spain, Madrid; Pharmazan-Spain, Barcelona; Hospital Clonico San Carlos, Madrid; School of Medicine, Universidad Complutense, Madrid; Hospital 12 de Octubre, Madrid, Spain
 show all
Pages 95-100 | Published online: 08 Jul 2009

Citations (44)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (12)

Claudio Borghi & Francesca Santi. (2012) Fixed combination of lercanidipine and enalapril in the management of hypertension: focus on patient preference and adherence. Patient Preference and Adherence 6, pages 449-455.
Read now
Carlos Escobar, Rocio Echarri & Vivencio Barrios. (2012) Emerging drug combinations to optimize renovascular protection and blood pressure goals. International Journal of Nephrology and Renovascular Disease 5, pages 69-80.
Read now
Miguel A. Ruiz, Antonio Pardo, Jose M. Martinez de la Casa, Vicente Polo, Jordi Esquiro & Javier Soto. (2010) Development of a Specific Questionnaire Measuring Patient Satisfaction with Glaucoma Treatment: Glausat. Ophthalmic Epidemiology 17:3, pages 131-143.
Read now
N.R. Robles, B. Romero, E. Garcia de Vinuesa, E. Sánchez-Casado & J.J. Cubero. (2010) Treatment of Proteinuria with Lercanidipine Associated with Renin-Angiotensin Axis-Blocking Drugs. Renal Failure 32:2, pages 192-197.
Read now
Michel Burnier, Menno Pruijm & Gregoire Wuerzner. (2009) Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?. Expert Opinion on Drug Metabolism & Toxicology 5:8, pages 981-987.
Read now
Menno T Pruijm, Marc P Maillard & Michel Burnier. (2008) Patient adherence and the choice of antihypertensive drugs: focus on lercanidipine. Vascular Health and Risk Management 4:6, pages 1159-1166.
Read now
Vivencio Barrios, Carlos Escobar & Rocio Echarri. (2008) Fixed combinations in the management of hypertension: perspectives on lercanidipine – enalapril. Vascular Health and Risk Management 4:4, pages 847-853.
Read now
Michel Burnier & Urs E Gasser. (2007) Efficacy and tolerability of lercanidipine in patients with hypertension: results of a Phase IV study in general practice. Expert Opinion on Pharmacotherapy 8:14, pages 2215-2223.
Read now
J Tisaire-Sánchez, J Roma, Ignacio CamachoAzcargorta, J Bueno-Gómez, J Mora-Maciá & Angel Navarro. (2006) Assessment of cognitive function in patients with essential hypertension treated with lercanidipine. Vascular Health and Risk Management 2:4, pages 491-498.
Read now
Claudio Borghi. (2005) Lercanidipine in Hypertension. Vascular Health and Risk Management 1:3, pages 173-182.
Read now
Niclás Roberto Robles, J Ocon, C F Gomez, M Manjon, L Pastor, J Herrera, J Villatoro, J Calls, J Torrijos, V I Rodríguez, M M. A Rodriguez, M L Mendez, A Morey, F I Martinez, J Marco, A Liebana, B Rincon & F Tornero. (2005) Lercanidipine in Patients with Chronic Renal Failure: The ZAFRA Study. Renal Failure 27:1, pages 73-80.
Read now
CLAUDIO BORGHI, MARIA GRAZIA PRANDIN, ADA DORMI & ETTORE AMBROSIONI. (2003) Improved Tolerability of the Dihydropyridine Calcium-Channel Antagonist Lercanidipine: The Lercanidipine Challenge Trial. Blood Pressure 12:sup1, pages 14-21.
Read now

Articles from other publishers (30)

Milena Pandrc & Vanja Kostovski. (2023) Metabolic neutral nephroprotective antihypertensive drugs: Beta blockers and calcium channel blockers. Galenika Medical Journal 2:6, pages 34-38.
Crossref
Marina G. Bubnova. (2022) Optimizing therapy for cardiovascular diseases: proven organ-protective and preventive effects of pitavastatin and lercanidipine: A review. CardioSomatics 13:1, pages 31-42.
Crossref
Giuseppe Mancia & Kostantinos Tsioufis. (2019) Current perspective on the use of calcium channel blockers to treat hypertensive patients: the role of lercanidipine. Future Cardiology 15:4, pages 259-266.
Crossref
I I Afonicheva, M V Melnik, S A Knyazeva & A A Kazyulin. (2018) Organoprotection with arterial hypertension 2-3 degrees. Systemic Hypertension 15:4, pages 47-52.
Crossref
F. Fici, G. Seravalle, N. Koylan, I. Nalbantgil, N. Cagla, Y. Korkut, F. Quarti-Trevano, W. Makel & G. Grassi. (2017) Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up. High Blood Pressure & Cardiovascular Prevention 24:3, pages 289-296.
Crossref
Guido Grassi, NicolàsR Robles, Gino Seravalle & Francesco Fici. (2017) Lercanidipine in the management of hypertension: An update. Journal of Pharmacology and Pharmacotherapeutics 8:4, pages 155.
Crossref
G S Anikin. (2014) Pleiotropic features of dihydropyridine calcium channel antagonists. Systemic Hypertension 11:3, pages 81-83.
Crossref
G. G Shehyan, A. A Yalymov, V. S Zadionchenko & S. I Varentsov. (2014) Application of lercanidipine in the treatment of hypertension. CardioSomatics 5:2, pages 46-50.
Crossref
G. A Baryshnikova, S. A Chorbinskaya & I. I Stepanova. (2014) Calcium antagonist lercanidipine in hypertension. CardioSomatics 5:1, pages 9-15.
Crossref
Viktor Viktorovich Fomin & Sergey Valentinovich Moiseev. (2013) Sovershenstvovanie podkhodov k primeneniyu antagonistov kal'tsiya: fokus na lerkanidipin. CardioSomatics 4:3, pages 42-45.
Crossref
A V Rodionov. (2013) Combined pharmacotherapy for arterial hypertension: a view through the 2013 clinical practice guidelines. Systemic Hypertension 10:2, pages 5-8.
Crossref
A A Kirichenko. (2013) Real and potential benefits of third-generation calcium antagonists. Systemic Hypertension 10:1, pages 57-61.
Crossref
N. R. Robles, B. Romero, E. Garcia de Vinuesa, E. Sánchez-Casado & J. J. Cubero. (2011) Treatment of proteinuria with lercanidipine associated with reninangiotensin axis-blocking drugs. Cardiovascular Therapy and Prevention 10:3, pages 83-88.
Crossref
J. Abellán Alemán, V. Gil Guillén, J. Merino Sánchez, J.L. Llisterri Caro & M. Leal Hernández. (2009) Estudio de farmacovigilancia con lercanidipino. Datos del estudio ZANyCONTROL. Hipertensión y Riesgo Vascular 26:3, pages 105-111.
Crossref
V. Barrios, C. Escobar, M. De La Figuera, J. Honorato, J. L. Llisterri, J. Segura & A. Calderón. (2008) High doses of lercanidipine are better tolerated than other dihydropyridines in hypertensive patients with metabolic syndrome: results from the TOLERANCE study. International Journal of Clinical Practice 62:5, pages 723-728.
Crossref
Vivencio Barrios, Carlos Escobar, Mariano De La Figuera, Jose Luis Llisterri, Jesus Honorato, Julián Segura & Alberto Calderón. (2008) Tolerability of High Doses of Lercanidipine versus High Doses of Other Dihydropyridines in Daily Clinical Practice: The TOLERANCE Study. Cardiovascular Drug Reviews 26:1, pages 2-9.
Crossref
Vivencio Barrios, Carlos Escobar, Juan Antonio Divison & Francisco Medialdea. (2007) Clinical experience with a low-dose fixed combination of perindopril plus indapamide in a primary-care setting: the PRETEND study. Therapy 4:5, pages 677-683.
Crossref
Vivencio Barrios, Carlos Escobar, Ángel Navarro, Alberto Calderón & Luis M Ruilope. (2007) Antihypertensive effectiveness of lercanidipine administered using an electronic pillbox compared with usual care in a cohort of mild-to-moderately hypertensive patients: the ELECTRA study. Therapy 4:4, pages 433-440.
Crossref
V. Barrios, C. Escobar, A. Navarro, R. Echarri, L. Barrios, J. Navarro-Cid & A. Calderón. (2007) Efectividad y tolerabilidad de lercanidipino en los pacientes hipertensos de alto riesgo. Datos del estudio LAURA. Hipertensión 24:4, pages 157-163.
Crossref
N M Chikhladze & I E Chazova. (2007) Lerkanidipin – novyy blokator kal'tsievykh kanalov: effektivnost' primeneniya u bol'nykh arterial'noy gipertoniey. Systemic Hypertension 4:1, pages 45-48.
Crossref
Cherylyn Beckey, Amber Lundy & Nahla Lutfi. (2016) Lercanidipine in the Treatment of Hypertension. Annals of Pharmacotherapy 41:3, pages 465-474.
Crossref
V. Barrios, C. Escobar, A. Navarro, R. Echarri, L. Barrios, J. Navarro-Cid & A. Calderón. (2007) Efectividad y tolerabilidad de lercanidipino en los pacientes hipertensos de alto riesgo. Datos del estudio LAURA. Hipertensión y Riesgo Vascular 24:4, pages 157-163.
Crossref
V. BARRIOS, C. ESCOBAR, Á. NAVARRO, L. BARRIOS, J. NAVARRO-CID & A. CALDERÓN. (2006) Lercanidipine is an effective and well tolerated antihypertensive drug regardless the cardiovascular risk profile: the LAURA Study. International Journal of Clinical Practice 60:11, pages 1364-1370.
Crossref
Rahul Agrawal, Axel Marx & Hermann Haller. (2006) Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension. Journal of Hypertension 24:1, pages 185-192.
Crossref
G. M. Bronskaya, M. Moubarak Ali, O. L. Palkovsky & V. P. Vdovichenko. (2005) DIHYDROPIRIDINE CALCIUM ANTAGONISTS OF III GENERATION IN TREATMENT OF ARTERIAL HYPERTENSION. Health and Ecology Issues:4, pages 17-25.
Crossref
Etzel Gysling. (2005) Lercanidipin. pharma-kritik 26:16.
Crossref
V. Barrios Alonso, J.P. Tomás Zarlenga, A. Calderón Montero & C. Escobar Cervantes. (2005) Papel de los ARA-II en el tratamiento de la hipertensión arterial. De la evidencia a la práctica clínica. Clínica e Investigación en Arteriosclerosis 17, pages 70-82.
Crossref
Edoardo Casiglia, Alberto Mazza, Valérie Tikhonoff, Giancarlo Basso, Bortolo Martini, Roberta Scarpa & Achille Cesare Pessina. (2004) Therapeutic profile of manidipine and lercanidipine in hypertensive patients. Advances in Therapy 21:6, pages 357-369.
Crossref
V. Barrios Alonso, J.P. Tomás Zarlenga, A. Navarro Lima, A. Esteras Sierra, M. Luque Otero, J. Romero Julia, J. Tamargo Menéndez, L. Prieto Valiente, I. Herranz Tejedor, J. Navarro Cid & L.M. Ruilope Urioste. (2003) Efectividad antihipertensiva y tolerabilidad de lercanidipino en diabéticos, en pacientes con hipertensión sistólica aislada y en ancianos. Análisis de subgrupos del estudio ELYPSE. Hipertensión y Riesgo Vascular 20:8, pages 347-353.
Crossref
José Ramón González-Juanatey, Pilar Mazón Ramos, Federico Soria Arcos, Vivencio Barrios Alonso, Luis Rodríguez Padial & Vicente Bertomeu Martínez. (2003) Actualización (2003) de las Guías de Práctica Clínica de la Sociedad Española de Cardiología en hipertensión arterial. Revista Española de Cardiología 56:5, pages 487-497.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.